I-Mab Provides Updates on Status under Holding Foreign Companies Accountable Act
May 5, 2022 — 20:00 CST
This Data Is Locked!
This area is available only to Subscribers.
SHANGHAI and GAITHERSBURG, Md., May 5, 2022 /PRNewswire/ -- I-Mab ("I-Mab" or the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discov...... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
